Seminoma Clinical Trials

Completed

Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation

NCT00003883

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

University of Washington Medical Center Seattle, Washington, United States

View Trial Details

Completed

Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors

NCT00004157

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +94 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation

NCT00014391

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +107 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Active, Not Recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

NCT02834013

Conditions: Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States

Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

View all 1007 locations

View Trial Details

Active, Not Recruiting

Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors

NCT02375204

Conditions: Adenocarcinoma, Carcinoma, Childhood Teratoma, +22 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

Loma Linda University Medical Center Loma Linda, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

View all 125 locations

View Trial Details

Active, Not Recruiting

Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma

NCT02537548

Conditions: Germinoma, Hemic and Lymphatic Diseases, Lymphadenopathy, +7 more
Locations: Loma Linda University Medical Center Loma Linda, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

University of California, San Francisco San Francisco, California, United States

Stanford University Hospitals & Clinics Stanford, California, United States

View all 14 locations

View Trial Details

Active, Not Recruiting

A Study of miRNA 371 in Patients With Germ Cell Tumors

NCT04435756

Conditions: Endocrine Gland Neoplasms, Endocrine System Diseases, Genital Diseases, +20 more
Locations: Banner MD Anderson Cancer Center Gilbert, Arizona, United States

Kingman Regional Medical Center Kingman, Arizona, United States

University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States

Banner University Medical Center - Tucson Tucson, Arizona, United States

View all 424 locations

View Trial Details

Active, Not Recruiting

Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors

NCT03158064

Conditions: Dysgerminoma, Germ Cell Tumor, Germinoma, +8 more
Locations: Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen Montvale, New Jersey, United States

Memorial Sloan Kettering Commack Commack, New York, United States

View Trial Details

Active, Not Recruiting

Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma

NCT03937843

Conditions: Endocrine Gland Neoplasms, Endocrine System Diseases, Genital Diseases, +15 more
Locations: Rotkreuzklinikum München München, Germany

Vivantes Klinikum Am Urban Berlin, Germany

Helios Klinikum Berlin-Buch Berlin, Germany

Evang. Kliniken Essen-Mitte Essen, Germany

View all 19 locations

View Trial Details

Active, Not Recruiting

A Phase II Trial of Cabozantinib With Patients With Refractory GCTs

NCT04876456

Conditions: Germ Cell Tumor, Germinoma, Neoplasms, +6 more
Locations: Indiana University Melvin & Bren Simon Cancer Center Indianapolis, Indiana, United States

View Trial Details

Seminoma

Seminoma trial results

Related conditions